Il Yang Pharmaceutical Umsatz, Kennzahlen, Bilanz/GuV

Il Yang Pharmaceutical: Die Aktie (in KRW)

2023202220212020201920182017
-140,001.036,00790,00597,00548,00-269,00-51,00
-139,101.036,59790,09597,61548,47-269,35-51,28
-139,101.036,59790,09597,61548,47-269,35-51,28
150,00150,00200,00120,00120,000,000,00
3.875,713.942,268.773,474.901,515.815,171.978,715.259,42

Il Yang Pharmaceutical: Unternehmenskennzahlen (in KRW)

2023202220212020201920182017
20.563,9121.175,2120.397,9018.858,8517.828,6316.516,3314.854,65
-18,6735,50110,1141,11--
-18,6735,50110,1141,11--
0,960,780,710,180,530,000,00
56,0958,0154,9855,7850,9248,5548,69
43,9141,9945,0244,2249,0851,4551,31

Il Yang Pharmaceutical: GuV (in Mio. KRW)

2023202220212020201920182017
370.537,41383.810,82371.347,51343.328,72324.573,44300.036,33269.811,00
-3,463,368,165,788,1811,203,13
198.961,98214.812,23203.658,79180.658,90177.754,99154.294,32130.757,00
-7,385,4812,731,6315,2118,0011,02
24.812,8640.407,5441.025,0134.100,8632.510,9316.721,9823.974,79
-38,59-1,5120,304,8994,42-30,253,42
3.048,1141.331,4038.927,3728.392,7427.660,888.069,1711.011,44
-92,636,1837,102,65242,80-26,72-32,19
-2.506,4118.788,6614.383,7510.879,589.984,92-4.893,03-931,39
-30,6232,218,96--425,35-

Il Yang Pharmaceutical: Bilanz (in Mio. KRW)

2023202220212020201920182017
205.875211.269222.513194.195214.717222.373225.390
1.782,611.346,521.334,97936,401.888,882.124,851.028,52
263.028291.854271.758244.922222.739209.880213.866
-3,304,738,215,265,05-4,34-2,39
468.903503.123494.271439.117437.456432.253439.256
-6,801,7912,560,381,20-1,591,85

Il Yang Pharmaceutical: sonstige Angaben (in KRW)

2023202220212020201920182017
-139,101.036,59790,09597,61548,47-269,35-51,28
-113,4231,2032,218,96--425,27-116,18
-139,101.036,59790,09597,61548,47-269,35-51,28
-113,4231,2032,218,96--425,27-116,18
150,00150,00200,00120,00120,000,000,00
0,00-25,0066,670,00---100,00
641655636651631624622
-2,142,99-2,303,171,120,321,14
Die Daten werden von FactSet zur Verfügung gestellt.
FactSet vereinheitlicht die Rechnungslegungsstandards IFRS und US-GAAP, um Unternehmenszahlen branchen- und länderübergreifend vergleichbar zu machen.